[Are metoclopramide and propranolol contraindicated, like nonsteroidal anti-inflammatory agents, in patients with cirrhosis and ascites?].
作者信息
Braillon A, Tribout B, Reix N, Capron J P
出版信息
Gastroenterol Clin Biol. 1986 Mar;10(3):231-3.
PMID:3732733
Abstract
摘要
相似文献
1
[Are metoclopramide and propranolol contraindicated, like nonsteroidal anti-inflammatory agents, in patients with cirrhosis and ascites?].对于肝硬化腹水患者，甲氧氯普胺和普萘洛尔是否像非甾体类抗炎药一样禁忌使用？
Gastroenterol Clin Biol. 1986 Mar;10(3):231-3.
2
Propranolol in the treatment of cirrhotic ascites.
Arch Intern Med. 1984 Sep;144(9):1761-3.
3
Optimum use of diuretics in managing ascites in patients with cirrhosis.肝硬化患者腹水管理中利尿剂的优化使用。
Gut. 2010 Jan;59(1):10-1. doi: 10.1136/gut.2009.189506.
4
Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.可乐定对肝硬化腹水患者利尿反应及交感神经系统激活的影响。
Hepatology. 2006 Oct;44(4):844-9. doi: 10.1002/hep.21355.
5
Use of diuretics in the treatment of cirrhotic ascites.
Gastroenterology. 1983 May;84(5 Pt 1):1051-5.
6
Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?心脏功能障碍能否解释β受体阻滞剂在肝硬化和顽固性腹水中的有害作用？
Hepatology. 2011 Jan;53(1):370-1. doi: 10.1002/hep.23857. Epub 2010 Jul 29.
7
Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.β受体阻滞剂对肝硬化难治性腹水患者生存率的有害影响。
Hepatology. 2011 Apr;53(4):1411-2. doi: 10.1002/hep.24051. Epub 2011 Jan 10.
8
Midodrine and furosemide-induced natriuresis in cirrhotics with ascites.米多君和呋塞米诱导肝硬化腹水患者的利钠作用。
Aliment Pharmacol Ther. 2011 Feb;33(3):415-6. doi: 10.1111/j.1365-2036.2010.04536.x.
9
Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Arch Intern Med. 1973 Jul;132(1):38-41.
10
Zotero 插件